Combinations of drugs in the Treatment of Obesity
Obesity is a chronic disease associated with excess morbidity and mortality. Clinical treatment, however, currently offers disappointing results, with very high rates of weight loss failure or weight regain cycles, and only two drugs (orlistat and sibutramine) approved for long-term use. Drugs combi...
Saved in:
Main Authors: | Marcio C. Mancini (Author), Maria Edna de Melo (Author), Cintia Cercato (Author), Alfredo Halpern (Author), André M. Faria (Author), Eduardo S. L. Oliveira (Author), Bruno Halpern (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients
by: Alfredo Halpern, et al.
Published: (2010) -
O diagnóstico de síndrome metabólica é aplicável às crianças? Is a diagnosis of metabolic syndrome applicable to children?
by: Rafael Nardini Queiroz Pergher, et al.
Published: (2010) -
Pharmacologic Treatment of Obesity
by: Alfredo Halpern, et al.
Published: (2011) -
Neighborhood and Individual Sociodemographic Characteristics Associated with Disparities in Adult Obesity and Perceptions of the Home Food Environment
by: Michael T. Halpern, et al.
Published: (2017) -
Enseñanzas de la pandemia de COVID-19 en América Latina: la vulnerabilidad genera más vulnerabilidad
by: Bruno Halpern, et al.
Published: (2022)